DUBLIN--(BUSINESS WIRE)--The "Global Psoriasis Market and Competitive Landscape - 2017" report has been added to Research and Markets' offering.
The latest research, Global Psoriasis Market and Competitive Landscape - 2017, provides comprehensive insights into Psoriasis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Psoriasis market size and drug sales. This research also provides insights into Psoriasis epidemiology and late stage pipeline.
The report is classified into twelve sections - Psoriasis overview with definitions, symptoms, etiology, diagnosis, treatment options; Psoriasis pipeline insights covering late stage clinical trials pipeline; Psoriasis prevalence trends by countries; Psoriasis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.
Research Scope:
- Psoriasis pipeline: Find out the drugs in clinical trials for Psoriasis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
- Psoriasis epidemiology: Find out the prevalence of Psoriasis by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
- Psoriasis products: Identify key products marketed and prescribed for Psoriasis by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
- Psoriasis market size: Find out the market size for Psoriasis drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
- Psoriasis drug sales: Find out the sales of Psoriasis drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
- Psoriasis drugs sales forecast: Sales forecast for Psoriasis drugs to 2021 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
-
Psoriasis market share analysis: Find out the market shares of
Psoriasis drugs and outlook by countries - US, Europe, Germany,
France, Italy, Spain, UK, Japan
For more information about this report visit https://www.researchandmarkets.com/research/n8tsmr/global_psoriasis
